[ad_1]
Executive informed that he is in contact with two laboratories; 2 million syringes are already in stock, according to mayor
The path to vaccinate the population of Belo Horizonte against Covid-19 begins to become clear. This Monday (7), the capital city council confirmed that it is in contact with two laboratories that are in an advanced stage of development of the vaccine against the virus. The Butantan Institute, in São Paulo, and Bio-Manguinhos / Fiocruz, in Rio de Janeiro, are the two companies with which the management of Alexandre Kalil (PSD) has already contacted for the purchase of the immunizer.
Cautiously, the municipal administration does not confirm or deny that the purchase was actually made, and points out that “the definition of the National Health Surveillance Agency (Anvisa) and the Ministry of Health is awaited to plan the vaccination campaign against Covid- 19 “.
The Butantan Institute was responsible for the trials in Brazil of CoronaVac, the Covid-19 vaccine developed by the Chinese pharmaceutical company Sinovac. Vaccination in São Paulo should begin on January 25. Bio-Manguinhos / Fiocruz develops the vaccine with the University of Oxford. However, these and any other immunizers can only be used after authorization from Anvisa.
Earlier, the governor of São Paulo, João Doria, stated that 4 million doses of CoronaVac will be sold to other units of the federation, and that eight states have already requested the immunizer from the Butantan Institute. “Some governors have even come here to discuss this matter with us,” Doria said, without naming names. He mentioned only two mayors interested in acquiring the vaccine: Rafael Greca (DEM), re-elected in Curitiba, and Eduardo Paes (DEM), elected in Rio de Janeiro. The São Paulo government did not want to inform which states are interested in the vaccine and the Butantan Institute declared that negotiations with the states are still in an initial phase.
Mayor Kalil has already given concrete proof that the city is working together to procure the vaccine. At a press conference held on November 25, he assured that the vaccination will take place anyway in the capital. “There is no risk for the population of Belo Horizonte without a vaccine. We already have 2 million ampoules in stock, if necessary, ”said the CEO. “We have separate money for the purchase (of the vaccine), which is authorized,” he added.
Positioning of the state government
When consulted, the state government ratified the negotiation with another laboratory, as anticipated TIME. The State is negotiating, through the Ezequiel Dias Foundation (Funed), with Covaxx, a division of United States United Biomedical. The lab is developing a vaccine against Covid-19, but the tests are still in phase 1, further delayed than the vaccines tested by Butantan and Bio-Manguinhos, for example.
The negotiation, however, arose from a meeting of businessmen from Minas Gerais who agreed to invest R $ 15 million to test this immunizer in Brazil. The costs to the state coffers are not yet clear.
According to the State, during this week there should be “news on the subject.” “This is an initial conversation with one of the potential partners who can contribute to the supply / production of the covid-19 vaccine in the state,” the government said, in a statement.
The next step is to sign the contract, which should happen within 60 days. The forecast is that testing of the Covaxx vaccine will be completed in May 2021. If all goes well, the partnership may result in the guarantee of 25 million doses for Minas Gerais. “We emphasize that any definition of the vaccination strategy in Minas Gerais will work in line with the Vaccination Contingency Plan against covid-19, prepared by SES-MG, and the National Immunization Program (PNI) of the Ministry of Health” , completed the government through a statement.
The management of Romeu Zema (Novo) has also secured the purchase of 50 million syringes, whose delivery is scheduled for the end of December.
[ad_2]
